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Introduction
The vitamin D endocrine system in many genera of New World primates (platyrrhini) is characterized by a compen-sated form of target organ resistance to the active metabolite of vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH)2-D3) (1) (2) (3) (4) (5) . When compared with Old World primates (catarrhini), the platyrrhine phenotype is typified by: (a) high circulating concentrations of 1 ,25(OH)2-D in the absence ofhyperparathyroidism (6) ; (b) the development of vitamin D-deficient rickets and osteomalacia in some captive platyrrhine species when environmental sunlight exposure is limited (2, 5) ; (c) a decrease in the cellular content of high affinity receptor for 1,25(OH)2-D3 (VDR)' demonstrable by radiolabeled ligand binding analyses (2, 4, 7, 8) ; and (d) a decrease in cellular indices of 1,25(OH)2-D3-VDR-directed bioaction without an apparent alteration in the nuclear localization and binding of the VDR-hormone complex (2) . Similar observations have been made in platyrrhini for other steroid hormones including glucocorticoids, sex steroids, and mineralocorticoids (9) . The phenotypic expression of resistance to 1,25(OH)2-D3 (as well as other steroid hormones) in various genera of platyrrhini appears to be heterogeneous (8, 9) . Platyrrhines in the family Callitricidae and some in the family Cebidae exhibit a marked decrement in the cellular content of bioeffective VDR and have a several-fold increase in the serum concentration of 1 ,25(OH)2-D (5, 8; Fig. 1 ). On the other hand, nocturnal cebids in the genus Aotus (night monkey or owl monkey) have a cellular receptor phenotype and serum levels of 1,25(OH)2-D that closely approximate those found in catarrhini, including Homo sapiens (8; Fig. 1 ). The reason for quantitative differences in the cellular content of functional VDR among New World primate genera is not known. In this report we demonstrate by immunoblot analysis using a monoclonal antibody developed against the VDR (10) quantitative and qualitative similarity of the VDR extracted from catarrhine and platyrrhine cells. In addition, we describe the presence of a factor extracted from cultured platyrrhine cells that disallows 1,25(OH)2-D3 binding to VDR extracted from cells derived from catarrhine hosts, Aotus trivergatus, and bovine thymus gland.
Methods
Primates. Blood and 4-mm transdermal biopsies were (13, 14) . After an 18-h period of preincubation in serum-free medium, confluent fibroblast cultures were harvested and suspended in 200 gl Ham's F-10 medium (pH 7.4) containing 25 The cells were pelleted, washed twice in ETD buffer (KETD buffer without KCI), and homogenized (P-10 polytron; Brinkmann Instruments, Inc., Westbury, NY) in the same buffer. Nuclei, with associated VDR, were pelleted at 4,000 g for 20 min at 4°C. The nuclear pellet was washed successively in: ETD buffer; 250 mM NaCl containing 8 mM EDTA; 10 mM Tris-HCI (pH 7.4) containing 1% Triton X-100; and 10 mM Tris-HCI (pH 7.4). All of the above buffers contained 5 mM DTT and 1 mM PMSF. The pellet was resuspended in KETD buffer, kept on ice for 30 min, and centrifuged once again at 14,000 g at 4°C for 30 min. The supernatant containing extracted VDR was collected, frozen, and stored at -70°C until used. These nuclear extracts, diluted to the desired volume with KETD buffer, were incubated with [3H]-1 ,25(OH)2-D3 in the presence or absence of 100 nM 1 ,25(OH)2-D3 for I h at 25°C. Tryptic digestion of B95-8 cell nuclear extracts was achieved by incubation of extracts with trypsin (Sigma Chemical Co., St. Louis, MO) 125 /g/ml for 30 min at 37°C, before terminating the enzymatic reaction with trypsin inhibitor (Sigma) 125 ug/ml for 15 min at 0°C before reconstitution with OMK extract and exposure to radiolabeled hormone. Heat inactivation of B95-8 cell nuclear extract was accomplished by warming extracts to 70°C for 30 min before mixing with wild type OMK extract and determination of specific 1,25(OH)2-D3 binding. VDR-bound hormone was separated from unbound hormone by dextran-coated charcoal ( 15) or on DEAE cellulose filters ( 16) . Mixing experiments were performed by assessing specific 1,25(OH)2-D3 binding in intergenus mixes of extracts of known protein concentration. Protein content of extracts was determined according to the method of Bradford (17) .
Immunoblot detection of VDR. Concentrated nuclear extracts were suspended in electrophoresis buffer containing 0.02 M Tris-HCI, 1% SDS, and 5% glycine, and heated at 90°C for 10 min. The denatured samples were loaded onto 11% SDS-polyacrylamide gels (Mini-Protein; Bio-Rad Laboratories, Richmond, CA) as described by Laemmli ( 18) and electrophoresed for 0.5 h at a fixed voltage of 200. The gels were transblotted onto nitrocellulose (Bio-Rad, 0.45-gm pore size) for 12 min at 100 V in transblot buffer containing 25 mM Tris HCI, 192 mM glycine, 0.1% SDS, and 20% methanol. Nitrocellulose membranes were blocked in 1% Blotto (instant nonfat dry milk; Carnation Co., Los Angeles, CA) in PBS for I h at 25°C and then transferred to 0.5% Blotto in PBS containing 4 ug/ml rat anti-chick VDR monoclonal antibody (9A7, kindly provided by Dr. M. R. Haussler and Dr. J. W. Pike, University of Arizona School of Medicine and Baylor College of Medicine, respectively). After an overnight incubation at 4°C with gentle rocking, the membranes were washed three times in Tris-buffered saline (50 mM Tris-HCI in 200 mM NaCl; pH 7.4) for 15 min at 25°C. The membranes were then transferred to 0.5% Blotto in PBS containing peroxidase-conjugated goat anti-rat IgG (Cappel Laboratories, Malvern, PA) and incubated for 2 h at 25°C. The membranes were once again washed three times in Tris-buffered saline for 15 min at 25°C and then developed with 4-chloro-I -napthol (19) .
Results
Quantitation of VDR. Immunodetection of the VDR in nuclear extracts ofcultured dermal fibroblasts ofcomparable protein content from three different individual primates in three different genera is shown in Fig. 2 In addition to demonstrating identical elution positions on Laemmli gels, the steady-state level of extractable VDR appeared to be quantitatively similar among cells from the three prototypic genera examined (Fig. 2 A) . This observation was confirmed in densitometric analyses of Western blots of cellular extracts derived from nine different individual primates, three in each of the prototypic categories (Fig. 2 B) . When compared with VDR in extracts of calf thymus, there was no significant difference in the amount of 50-kD VDR detected among primates in different genera. Despite a quantitative similarity in the cellular concentration of immunodetectable VDR, there was a dramatic difference in the cellular content of VDR when assessed by specific ligand binding analyses (Fig. 2 C) Fig. 3 B) ; the owl monkey appears to express a wild type VDR even though this species is a New World primate (8) . The effect of mixing a given concentration ofwild type extract with increasing dilutions ofresistant extract is shown in Fig. 4 (Fig. 2) . There are several potential explanations for this relative decrease in the cellular content of VDR in platyrrhines. The two most obvious explanations are decreased production or increased catabolism of VDR in platyrrhine cells. However, our data employing immunoblot detection of the protein suggest that there is quantitative as well as qualitative similarity in the steady-state levels of the 50-kD VDR species in cellular extracts from all genera of primates tested (Fig. 2) . There are, in turn, several possible explanations for the apparent discrepancy in the ligand binding and immunoblot data obtained in platyrrhine cells with the vitamin D-resistant phenotype.
First, it is possible that there is a structural alteration in the ligand binding domain of the receptor that in some way variably diminishes the total number of steroid molecules that can be bound. This possibility is unlikely in that one would expect such a change in the VDR to result in a concomitant change in the affinity of the VDR for 1,25(OH)2-D3. Previous reports from us (2, 8) (8) . Furthermore, diminished VDR-hormone binding activity persists in nuclear extracts of platyrrhine cells (Fig. 3 ) that should be devoid of mitochondrial vitamin D-24-hydroxylase activity.
A third possible explanation, compatible with the results of our mixing experiments (see Figs. 3 and 4) , is that platyrrhine cell nuclear extracts contain a soluble factor that prevents exogenous 1,25(OH)2-D3 from interacting with the hormone-binding domain of the VDR. The existence of such a factor is most compatible with the results represented here. Since this factor does not bind 1,25(OH)2-D3, it should not quantitatively affect the affinity of the VDR for 1,25(OH)2-D3 or the cellular concentration of immunodetectable, 50-kD VDR under denaturing gel conditions. Such a factor was also documented to be present in nuclear extracts ofthe B95-8 B-lymphoblast cell line derived from EBV-transformation of marmoset (Callithrixjacchus) peripheral blood cells (Fig. 5) , indicating that this factor is not specific for a particular platyrrhine species, a specific tissue, or primary cell culture. The factor is water soluble, and a substantial amount of it is colocalized, along with VDR, to the nucleus under "low salt" conditions. The factor along with VDR can be coextracted from the nucleus in "high salt" buffer. Although this factor does not appear to coelute with the VDR from DEAE cellulose HPLC through a gradient of KCI (0.05-0.5 M), it apparently does coelute with the VDR from isolated nuclei through a stepwise gradient of KCI (2 (27, (29) (30) (31) (32) (33) (34) (35) (36) , there is no evidence to suggest that the VDR is associated with heat shock proteins either in vivo or in vitro (37) .
A fourth potential explanation for the observed discrepancy in the ligand binding and immunoblot results obtained in platyrrhine cells is that there exists in platyrrhine cells another factor that competes with endogenous VDR for 1,25(OH)2-D3 binding. This explanation is compatible with the mixing experiments described in Figs. 3, 4 , and 5, which demonstrate that platyrrhine cell extracts contain a soluble factor that inhibits ligand binding to catarrhine and Aotus VDR and that this factor is relatively plentiful. Such a protein would not be expected to be bound by antireceptor antibody and, therefore, would not be detected by immunoblot analysis. Compared with the VDR, this protein would also have to exhibit higher capacity but much lower affinity for 1,25(OH)2-D3 as there is little or no specific binding of 1,25(OH)2-D3 to VDR from platyrrhine cells at radioligand concentrations 1 nM. A second binding moiety with such characteristics (high capacity and low affinity) has not yet been detected in platyrrhine cell nuclear extracts but investigation of the presence of such a factor in other cellular compartments is underway.
The VDR, receptors for other steroid hormones, as well as the intracellular receptor proteins for thyroid hormone and retinoic acid likely evolved from a common ancestral gene by reduplication (38) . These genetic events are relatively ancient when compared to the separation of the South American and African continental land masses (50-60 million years ago) and the independent evolution of platyrrhines and catarrhines. Therefore, if the platyrrhine phenotype of multiple steroid hormone resistance were due to mutational events at the level of the receptor proteins, one would have to postulate the occurrence of concurrent mutations in the ligand binding domain of each of the receptor genes. A far more plausible explanation would be genetic alteration of a single protein, like hsp-90 or a kinase, which has the potential to interact with the ligand binding domain of each and every one of these receptor proteins. Moreover, quantitative differences in the level of expression of this protein could give rise to the phenotypic heterogeneity in steroid hormone-receptor interactions observed among different genera of primates (8). 
